X3 Holdings announced a strategic partnership with an unnamed AI‑healthcare technology company to commercialize an AI‑powered smartwatch. The device employs a non‑invasive brainwave sensing chip and digital frequency modulation technology to monitor emotional and neurological balance, drawing on data from 7 million users and 25 000 physiological indicators.
The partnership marks X3’s first entry into the AI‑healthcare sector, expanding beyond its core businesses of digital trade, cryptomining, renewable energy, and smart agritech. X3 will leverage its global digital operations and cross‑border execution capabilities to roll out the device worldwide, with the first revenue‑generating service contracts expected to begin in March 2026.
X3’s financial performance in recent years has been challenging. Revenue fell 87.5% over the past three years and 30.99% in FY2024, declining from $16.8 million to $11.6 million. Operating and net margins were negative, at –718.3% and –855.45% respectively in FY2024. The company has also received a Nasdaq delisting notice and is appealing the decision, underscoring its precarious liquidity position.
The smartwatch partnership offers a potential high‑growth revenue stream, but its success will hinge on X3’s ability to overcome existing financial and operational hurdles. While the device is positioned to tap into the growing global trend toward preventive, data‑driven health management, the company’s limited cash reserves and ongoing compliance challenges could constrain its ability to scale the product quickly.
X3 has not yet disclosed the name of the AI‑healthcare partner, and no management commentary has been released regarding the strategic rationale or expected impact on the company’s earnings. Investors will likely view the partnership as a diversification attempt, but the lack of financial guidance and the company’s distressed status may temper enthusiasm.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.